Medical Membrane Market By Chemistry (Polyvinylidene Fluoride (PVDF), Polysulfone (PS), Polytetrafluoroethylene (PTFE), Polyethylene (PE), Modified Acrylics), By Technology (Microfiltration (MF), Reverse Osmosis & Dialysis, Ultrafiltration (UF), Nanofiltration), By Application (Pharmaceutical Filtration, Hemodialysis, Drug Delivery, Iv Infusion Filters And Sterile Filtration), Industry Size, Growth, Share And Forecast To 2022
Key Findings
The global medical membrane market is anticipated to grow at a robust CAGR of 10.2% for the forecast period 2016-2022, and is expected to generate a revenue of around $ 10131 million by 2022. A membrane is usually made from organic or inorganic materials like polymers, metals, glass, ceramics etc. Medical membranes are widely used in various applications such as healthcare, pharmaceutical, biotechnology, and life science industries. Membranes offer high permeability and selectivity, thus providing additional advantage. Properties and type of the membrane to be used for a particular application depends on various factors such as external environment, chemical compatibility, device fabrication, sterilization, degree of sterility required, biocompatibility, etc. The major factors driving the global medical membrane market are rising incidences of diabetes and kidney diseases; as well as, growing demand of artificial organs. According to International Diabetes Federation(IDF), in 2015, there were around $673 billion spent on 415 million diabetes patients worldwide, and the number of patients is expected torise up to 642 million by 2040. Around 75% of the diabetes patients live in developing countries. South East Asia, will have the highest number of diabetes patients by 2040, approximately 140.2 million.India has the world’s largest number of diabetic patients followed by China. This will help to boost the medical membrane market in the near future.In addition,increase investments in healthcare, pharmaceutical, and biotechnology industries; development of new innovative products due to technological advancements; increasing use of single-use disposable products; increasing patient base in emerging economies; and, the rise in requirement of selective separation, along with high level of purity are few factors that are accelerating the growth of global medical membrane market. However, short life-span of membranes due to membrane fouling; financial challenges such as high capital & operation cost; limitations of membrane materials; and, long in process validation process are the factors that are restraining the growth of the market.
Market Segment Insight
The global medical membrane market is segmented on the basis of chemistry, application andtechnology. On the basis of chemistry the market is segmented as Polyvinylidene Fluoride (PVDF), Polysulfone (PS), Polytetrafluoroethylene (PTFE), Polyethylene (PE), Modified Acrylics and others. PTFE is an inert material that possesses good flow properties, and also have high chemical resistance. PVDF market is expected to have a significant CAGR due to its good flow properties and broad chemical resistance. On the basis of technology, global medical membrane market is segmented as microfiltration, reverse osmosis & dialysis, ultrafiltration, nanofiltration, and others. The application segment comprises of pharmaceutical filtration, hemodialysis, drug delivery, IV infusion filters and sterile filtration, and others. Among various applications, Hemodialysis segment has been estimated to grow at the highest CAGR. The major reason for this growth is increasing incidences of diabetes and kidney related diseases. Apart from Hemodialysis, infusion filters & sterile filtration will generate tremendous opportunities for the medical membrane market.
Regional Insight
The major regional segments analyzed in the report include North America, Europe, Asia Pacific, and Rest of the World, with further bifurcation of them on country level, which includes U.S, Canada, India, China, Japan, Germany, U.K., Spain, Brazil etc. North America is the leader in global medical membrane market. This is due to various factors like increasing demand for membrane devices in the region, developed healthcare infrastructure, and technological advancement in the medical membrane field. In North America, U.S. represents the largest market followed Canada.However, Asia Pacific is the fastest growing market,and isanticipated to grow at the highest CAGR during the forecast period. Increasing demand of artificial organs in the region; growing government support; increasing investment by global players in the region due to less stringent regulations and low cost of labor; huge patient base; and, improving healthcare infrastructure are various factors stimulating the growth of the medical membrane market in the APAC region.
Competitive Insights
Medical Membrane is an attractive market for new entrants because of high returns on investment and high significant growth potential. Some of the keymarket players areAsahi Kasei Corporation; Baxter International; Fresenius Medical Care; Ge Water & Process Technologies; Hyflux Ltd.; Koch Membrane Systems Inc.; Merck Millipore (EMD Millipore);MICRODYN-NADIR GmbH; NxStage Medical Inc.; Pall Corporation; Spectrum Laboratories; Response Biomedical; The 3M Company; Thermo Fisher Scientific Inc.; W. L. Gore & Associates, Inc. Product innovations, Mergers & acquisition and collaborations are the key strategies adopted by the market players to sustain in the market and,to develop it further. In October 2015, Merck Millipore acquired Sigma-Aldrich chemical business to support its biochemical research for medical membranes.
CHAP 1. METHODOLOGY & SCOPE 12
1.1. RESEARCH METHODOLOGY 12
1.2. RESEARCH SCOPE & ASSUMPTIONS 12
1.3. LIST OF DATA SOURCES 12
CHAP 2. EXECUTIVE SUMMARY 13
2.1. GLOBAL MEDICAL MEMBRANE MARKET SUMMARY & KEY BUYING CRITERIA 13
2.2. GLOBAL MEDICAL MEMBRANE MARKET OUTLOOK 13
2.3. MARKET SEGMENTATION ANALYSIS 13
2.4. MARKET SIZE AND GROWTH PROSPECTS 2012-2022 13
2.5. GLOBAL MEDICAL MEMBRANE MARKET VALUE CHAIN ANALYSIS 13
2.6. VENDOR LANDSCAPE 13
CHAP 3. GLOBAL MEDICAL MEMBRANE MARKET 14
3.1. MARKET DRIVER ANALYSIS 14
3.1.1. INCREASING HEALTHCARE AND PHARMACEUTICAL INDUSTRIES 14
3.1.2. GROWING DEMAND FOR ARTIFICIAL ORGANS 14
3.1.3. REQUIREMENT OF SELECTIVE SEPARATION ALONG WITH HIGH LEVEL OF PURITY 14
3.1.4. RISING INCIDENCES OF CHRONIC DISEASES 14
3.2. MARKET RESTRAINT ANALYSIS 14
3.2.1. FINANCIAL CHALLENGES TO PROVIDE PRODUCTS AT AFFORDABLE PRICE 14
3.2.2. LONG IN-PROCESS VALIDATION PROCESS 14
3.3. KEY OPPORTUNITIES 14
3.3.1. GROWING DEMAND FOR MEMBRANES IN THE EMERGING ECONOMIES 14
3.4. CHALLENGES 14
3.4.1. LIFE SPAN OF MEMBRANES 14
CHAP 4. INDUSTRY ANALYSIS 15
4.1. GLOBAL MEDICAL MEMBRANE MARKET– PORTER’S FIVE FORCE MODEL 15
4.2. GLOBAL MEDICAL MEMBRANE MARKET – PESTEL ANALYSIS 15
4.3. GLOBAL MEDICAL MEMBRANE MARKET – GAP ANALYSIS 15
CHAP 5. GLOBAL MEDICAL MEMBRANE MARKET BY CHEMISTRY 2012-2022 ($ MILLION) 16
5.1. GLOBAL MEDICAL MEMBRANE MARKET BY POLYVINYLIDENE FLUORIDE (PVDF) 2012-2022 ($ MILLION) 16
5.2. GLOBAL MEDICAL MEMBRANE MARKET BY POLYSULFONE (PS) 2012-2022 ($ MILLION) 16
5.3. GLOBAL MEDICAL MEMBRANE MARKET BY POLYTETRAFLUOROETHYLENE (PTFE) 2012-2022 ($ MILLION) 16
5.4. GLOBAL MEDICAL MEMBRANE MARKET BY POLYETHYLENE (PE) 2012-2022 ($ MILLION) 16
5.5. GLOBAL MEDICAL MEMBRANE MARKET BY MODIFIED ACRYLICS 2012-2022 ($ MILLION) 16
5.6. GLOBAL MEDICAL MEMBRANE MARKET BY OTHERS TREATMENT 2012-2022 ($ MILLION) 16
CHAP 6. GLOBAL MEDICAL MEMBRANE MARKET BY TECHNOLOGY 2012-2022 ($ MILLION) 17
6.1. GLOBAL MEDICAL MEMBRANE MARKET BY MICROFILTRATION (MF) 2012-2022 ($ MILLION) 17
6.2. GLOBAL MEDICAL MEMBRANE MARKET BY REVERSE OSMOSIS & DIALYSIS 2012-2022 ($ MILLION) 17
6.3. GLOBAL MEDICAL MEMBRANE MARKET BY ULTRAFILTRATION (UF) 2012-2022 ($ MILLION) 17
6.4. GLOBAL MEDICAL MEMBRANE MARKET BY NANOFILTRATION 2012-2022 ($ MILLION) 17
6.5. GLOBAL MEDICAL MEMBRANE MARKET BY OTHER 2012-2022 ($ MILLION) 17
CHAP 7. GLOBAL MEDICAL MEMBRANE MARKET BY APPLICATION 2012-2022 ($ MILLION) 18
7.1. GLOBAL MEDICAL MEMBRANE MARKET BY PHARMACEUTICAL FILTRATION (MF) 2012-2022 ($ MILLION) 18
7.2. GLOBAL MEDICAL MEMBRANE MARKET BY HEMODIALYSIS 2012-2022 ($ MILLION) 18
7.3. GLOBAL MEDICAL MEMBRANE MARKET BY DRUG DELIVERY 2012-2022 ($ MILLION) 18
7.4. GLOBAL MEDICAL MEMBRANE MARKET BY IV INFUSION FILTERS AND STERILE FILTRATION 2012-2022 ($ MILLION) 18
7.5. GLOBAL MEDICAL MEMBRANE MARKET BY OTHER 2012-2022 ($ MILLION) 18
CHAP 8. GLOBAL MEDICAL MEMBRANE MARKET REGIONAL OUTLOOK 2012-2022 ($ MILLION) 19
8.1. GLOBAL MEDICAL MEMBRANE MARKET BY REGION 2012-2022 ($ MILLION) 19
8.2. NORTH AMERICA 19
8.2.1. NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
8.2.2. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 19
8.2.3. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 19
8.2.3.1. U.S. 19
8.2.3.1.1. U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
8.2.3.1.2. U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 19
8.2.3.2. CANADA 19
8.2.3.2.1. CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
8.2.3.2.2. CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 19
8.3. EUROPE 20
8.3.1. EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
8.3.2. EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
8.3.3. EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 20
8.3.3.1. GERMANY 20
8.3.3.1.1. GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
8.3.3.1.2. GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
8.3.3.2. UK 20
8.3.3.2.1. UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
8.3.3.2.2. UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
8.3.3.3. FRANCE 20
8.3.3.3.1. FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
8.3.3.3.2. FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
8.3.3.4. REST OF EUROPE 20
8.3.3.4.1. REST OF EUROPE MARKET ESTIMATES AND FORECAST2012-2022($MILLION) 21
8.3.3.4.2. REST OF EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($MILLION) 21
8.4. ASIA PACIFIC 21
8.4.1. ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
8.4.2. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
8.4.3. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 21
8.4.3.1. CHINA 21
8.4.3.1.1. CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
8.4.3.1.2. CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
8.4.3.2. INDIA 21
8.4.3.2.1. INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
8.4.3.2.2. INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
8.4.3.3. JAPAN 21
8.4.3.3.1. JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
8.4.3.3.2. JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($MILLION) 21
8.4.3.4. SOUTH KOREA 21
8.4.3.4.1. SOUTH KOREA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
8.4.3.4.2. SOUTH KOREA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($MILLION) 21
8.4.3.5. REST OF APAC 22
8.4.3.5.1. REST OF APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 22
8.4.3.5.2. REST OF APAC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 22
8.5. REST OF THE WORLD 22
8.5.1. REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 22
8.5.2. REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 22
8.5.3. REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 22
8.5.3.1. LATIN AMERICA 22
8.5.3.1.1. LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 22
8.5.3.1.2. LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 22
8.5.3.2. MIDDLE EAST AND AFRICA 22
8.5.3.2.1. MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 22
8.5.3.2.2. MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 22
CHAP 9. COMPETITIVE LANDSCAPE 23
9.1. ASAHI KASEI CORP. 24
9.1.1. COMPANY OVERVIEW 24
9.1.2. SCOT ANALYSIS 24
9.1.3. PRODUCT BENCHMARKING 24
9.1.4. STRATEGIC INITIATIVES 24
9.2. BAXTER INTERNATIONAL 24
9.2.1. COMPANY OVERVIEW 24
9.2.2. SCOT ANALYSIS 24
9.2.3. PRODUCT BENCHMARKING 24
9.2.4. STRATEGIC INITIATIVES 24
9.3. FRESENIUS MEDICAL CARE 24
9.3.1. COMPANY OVERVIEW 24
9.3.2. SCOT ANALYSIS 24
9.3.3. PRODUCT BENCHMARKING 24
9.3.4. STRATEGIC INITIATIVES 24
9.4. GE WATER AND PROCESS TECHNOLOGIES 24
9.4.1. COMPANY OVERVIEW 24
9.4.2. SCOT ANALYSIS 24
9.4.3. PRODUCT BENCHMARKING 24
9.4.4. STRATEGIC INITIATIVES 24
9.5. HYFLUX LTD 24
9.5.1. COMPANY OVERVIEW 24
9.5.2. SCOT ANALYSIS 24
9.5.3. PRODUCT BENCHMARKING 24
9.5.4. STRATEGIC INITIATIVES 24
9.6. KOCH MEMBRANE SYSTEMS INC 24
9.6.1. COMPANY OVERVIEW 24
9.6.2. SCOT ANALYSIS 25
9.6.3. PRODUCT BENCHMARKING 25
9.6.4. STRATEGIC INITIATIVES 25
9.7. MERK MILLIPORE 25
9.7.1. COMPANY OVERVIEW 25
9.7.2. SCOT ANALYSIS 25
9.7.3. PRODUCT BENCHMARKING 25
9.7.4. STRATEGIC INITIATIVES 25
9.8. MICRODYN NADIR GMBH 25
9.8.1. COMPANY OVERVIEW 25
9.8.2. SCOT ANALYSIS 25
9.8.3. PRODUCT BENCHMARKING 25
9.8.4. STRATEGIC INITIATIVES 25
9.9. NXSTAGE MEDICAL 25
9.9.1. COMPANY OVERVIEW 25
9.9.2. SCOT ANALYSIS 25
9.9.3. PRODUCT BENCHMARKING 25
9.9.4. STRATEGIC INITIATIVES 25
9.10. PALL CORP. 25
9.10.1. COMPANY OVERVIEW 25
9.10.2. SCOT ANALYSIS 25
9.10.3. PRODUCT BENCHMARKING 25
9.10.4. STRATEGIC INITIATIVES 25
9.11. SPECTRUM LABORATORIES 25
9.11.1. COMPANY OVERVIEW 25
9.11.2. SCOT ANALYSIS 25
9.11.3. PRODUCT BENCHMARKING 25
9.11.4. STRATEGIC INITIATIVES 25
9.12. RESPONSE BIOMEDICAL 26
9.12.1. COMPANY OVERVIEW 26
9.12.2. SCOT ANALYSIS 26
9.12.3. PRODUCT BENCHMARKING 26
9.12.4. STRATEGIC INITIATIVES 26
9.13. THE 3M COMPANY 26
9.13.1. COMPANY OVERVIEW 26
9.13.2. SCOT ANALYSIS 26
9.13.3. PRODUCT BENCHMARKING 26
9.13.4. STRATEGIC INITIATIVES 26
9.14. THERMO FISCHER SCIENTIFIC INC. 26
9.14.1. COMPANY OVERVIEW 26
9.14.2. SCOT ANALYSIS 26
9.14.3. PRODUCT BENCHMARKING 26
9.14.4. STRATEGIC INITIATIVES 26
9.15. W.L. GORE & ASSOCIATES, INC. 26
9.15.1. COMPANY OVERVIEW 26
9.15.2. SCOT ANALYSIS 26
9.15.3. PRODUCT BENCHMARKING 26
9.15.4. STRATEGIC INITIATIVES 26
TABLE 1 GLOBAL MEDICAL MEMBRANE MARKET BY CHEMISTRY 2012-2022 ($ MILLION) 26
TABLE 2 GLOBAL MEDICAL MEMBRANE MARKET BY POLYVINYLIDENE FLUORIDE (PVDF) 2012-2022 ($ MILLION) 26
TABLE 3 GLOBAL MEDICAL MEMBRANE MARKET BY POLYSULFONE (PS) 2012-2022 ($ MILLION) 26
TABLE 4 GLOBAL MEDICAL MEMBRANE MARKET BY POLYTETRAFLUOROETHYLENE (PTFE) 2012-2022 ($ MILLION) 27
TABLE 5 GLOBAL MEDICAL MEMBRANE MARKET BY POLYETHYLENE (PE) 2012-2022 ($ MILLION) 27
TABLE 6 GLOBAL MEDICAL MEMBRANE MARKET BY MODIFIED ACRYLICS 2012-2022 ($ MILLION) 27
TABLE 7 GLOBAL MEDICAL MEMBRANE MARKET BY OTHERS TREATMENT 2012-2022 ($ MILLION) 27
TABLE 8 GLOBAL MEDICAL MEMBRANE MARKET BY TECHNOLOGY 2012-2022 ($ MILLION) 27
TABLE 9 GLOBAL MEDICAL MEMBRANE MARKET BY MICROFILTRATION (MF) 2012-2022 ($ MILLION) 27
TABLE 10 GLOBAL MEDICAL MEMBRANE MARKET BY REVERSE OSMOSIS & DIALYSIS 2012-2022 ($ MILLION) 27
TABLE 11 GLOBAL MEDICAL MEMBRANE MARKET BY ULTRAFILTRATION (UF) 2012-2022 ($ MILLION) 27
TABLE 12 GLOBAL MEDICAL MEMBRANE MARKET BY NANOFILTRATION 2012-2022 ($ MILLION) 27
TABLE 13 GLOBAL MEDICAL MEMBRANE MARKET BY OTHER 2012-2022 ($ MILLION) 27
TABLE 14 GLOBAL MEDICAL MEMBRANE MARKET BY APPLICATION 2012-2022 ($ MILLION) 27
TABLE 15 GLOBAL MEDICAL MEMBRANE MARKET BY PHARMACEUTICAL FILTRATION (MF) 2012-2022 ($ MILLION) 27
TABLE 16 GLOBAL MEDICAL MEMBRANE MARKET BY HEMODIALYSIS 2012-2022 ($ MILLION) 27
TABLE 17 GLOBAL MEDICAL MEMBRANE MARKET BY DRUG DELIVERY 2012-2022 ($ MILLION) 27
TABLE 18 GLOBAL MEDICAL MEMBRANE MARKET BY IV INFUSION FILTERS AND STERILE FILTRATION 2012-2022 ($ MILLION) 27
TABLE 19 GLOBAL MEDICAL MEMBRANE MARKET BY OTHER 2012-2022 ($ MILLION) 27
TABLE 20 GLOBAL MEDICAL MEMBRANE MARKET REGIONAL OUTLOOK 2012-2022 ($ MILLION) 27
TABLE 21 GLOBAL MEDICAL MEMBRANE MARKET BY REGION 2012-2022 ($ MILLION) 28
TABLE 22 NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
TABLE 23 NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 28
TABLE 24 NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
TABLE 25 U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
TABLE 26 U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
TABLE 27 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
TABLE 28 CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
TABLE 29 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
TABLE 30 EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 28
TABLE 31 EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
TABLE 32 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
TABLE 33 GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
TABLE 34 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
TABLE 35 UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
TABLE 36 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
TABLE 37 FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
TABLE 38 REST OF EUROPE MARKET ESTIMATES AND FORECAST2012-2022 ($ MILLION) 29
TABLE 39 REST OF EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-202 2 ($ MILLION) 29
TABLE 40 ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
TABLE 41 ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 29
TABLE 42 ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 29
TABLE 43 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
TABLE 44 CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 29
TABLE 45 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
TABLE 46 INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 29
TABLE 47 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
TABLE 48 JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 29
TABLE 49 SOUTH KOREA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
TABLE 50 SOUTH KOREA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 29
TABLE 51 REST OF APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
TABLE 52 REST OF APAC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 29
TABLE 53 REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
TABLE 54 REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 29
TABLE 55 REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 30
TABLE 56 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
TABLE 57 LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 30
TABLE 58 MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
TABLE 59 MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 30
FIGURE 1 NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
FIGURE 2 U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
FIGURE 3 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
FIGURE 4 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
FIGURE 5 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
FIGURE 6 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
FIGURE 7 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
FIGURE 8 REST OF EUROPE MARKET ESTIMATES AND FORECAST2012-2022 ($ MILLION) 30
FIGURE 9 ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
FIGURE 10 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
FIGURE 11 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
FIGURE 12 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
FIGURE 13 SOUTH KOREA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
FIGURE 14 REST OF APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
FIGURE 15 REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
FIGURE 16 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
FIGURE 17 MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
Choose License
Contact Information
: sales@briskinsights.com
: +448081890034 (UK)